Kyntra Bio (KYNB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.85, -9.51% vs the prior close of $5.36.
- Volume 28.50K shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
KYNB slides 9.5% to $4.85, a 52-week low, 4 down days in a row. Closed at $4.85, -9.51% vs the prior close of $5.36. Day range $4.85–$5.50, opened at $5.39.
KYNB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — KYNB slides 9.5% to $4.85, a 52-week low, 4 down days in a row
- Closed at $4.85, -9.51% vs the prior close of $5.36. Day range $4.85–$5.50, opened at $5.39.
- Volume was 28.50K shares, 1.3x its 50-day average of 22.76K.
- Price is -32.0% vs its 50-day average ($7.13) and -33.7% vs its 200-day average ($7.32).
- 52-week range $4.85–$11.65; today's close sits at 0% of that range, 58.4% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — KYNB slides 3.7% to $5.36, a 52-week low, 3 down days in a row
- Closed at $5.36, -3.68% vs the prior close of $5.57. Day range $5.34–$5.73, opened at $5.50.
- Volume was 31.60K shares, 1.4x its 50-day average of 22.27K.
- Price is -25.3% vs its 50-day average ($7.17) and -27.0% vs its 200-day average ($7.34).
- 52-week range $5.34–$11.65; today's close sits at 0% of that range, 54.0% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — KYNB slides 5.2% to $5.57, a 52-week low
- Closed at $5.57, -5.20% vs the prior close of $5.87. Day range $5.46–$5.90, opened at $5.89.
- Volume was 36.70K shares, 1.7x its 50-day average of 21.71K.
- Price is -22.8% vs its 50-day average ($7.20) and -24.3% vs its 200-day average ($7.36).
- 52-week range $5.46–$11.65; today's close sits at 2% of that range, 52.2% below the 52-week high.
Oct 13, 2026 — KYNB slides 4.1% to $5.87, a 52-week low
- Closed at $5.87, -4.08% vs the prior close of $6.12. Day range $5.87–$6.21, opened at $6.21.
- Volume was 15.90K shares, 0.7x its 50-day average of 21.49K.
- Price is -18.8% vs its 50-day average ($7.23) and -20.4% vs its 200-day average ($7.37).
- 52-week range $5.62–$11.65; today's close sits at 4% of that range, 49.6% below the 52-week high.
Oct 12, 2026 — KYNB ends flat (+0.2%) to $6.12
- Closed at $6.12, +0.16% vs the prior close of $6.11. Day range $6.01–$6.34, opened at $6.15.
- Volume was 23.60K shares, 1.1x its 50-day average of 21.11K.
- Price is -15.6% vs its 50-day average ($7.25) and -17.1% vs its 200-day average ($7.39).
- 52-week range $5.62–$11.65; today's close sits at 8% of that range, 47.5% below the 52-week high.
Oct 9, 2026 — KYNB rises 2.5% to $6.11
- Closed at $6.11, +2.52% vs the prior close of $5.96. Day range $6.08–$6.26, opened at $6.08.
- Volume was 6.60K shares, 0.3x its 50-day average of 21.10K — lighter than usual.
- Price is -15.9% vs its 50-day average ($7.26) and -17.4% vs its 200-day average ($7.40).
- 52-week range $5.62–$11.65; today's close sits at 8% of that range, 47.6% below the 52-week high.
Oct 8, 2026 — KYNB dips 2.8% to $5.96
- Closed at $5.96, -2.77% vs the prior close of $6.13. Day range $5.90–$6.16, opened at $6.15.
- Volume was 15.00K shares, 0.7x its 50-day average of 20.93K.
- Price is -18.1% vs its 50-day average ($7.27) and -19.6% vs its 200-day average ($7.41).
- 52-week range $5.62–$11.65; today's close sits at 6% of that range, 48.8% below the 52-week high.
Oct 7, 2026 — KYNB rises 2.9% to $6.13
- Closed at $6.13, +2.85% vs the prior close of $5.96. Day range $5.85–$6.35, opened at $5.85.
- Volume was 16.80K shares, 0.8x its 50-day average of 20.77K.
- Price is -15.9% vs its 50-day average ($7.29) and -17.4% vs its 200-day average ($7.42).
- 52-week range $5.62–$11.65; today's close sits at 8% of that range, 47.4% below the 52-week high.
Oct 6, 2026 — KYNB dips 2.1% to $5.96, a 52-week low, 10 down days in a row
- Closed at $5.96, -2.13% vs the prior close of $6.09. Day range $5.87–$6.14, opened at $6.14.
- Volume was 13.70K shares, 0.7x its 50-day average of 20.59K.
- Price is -18.4% vs its 50-day average ($7.31) and -19.8% vs its 200-day average ($7.43).
- 52-week range $5.62–$12.13; today's close sits at 5% of that range, 50.9% below the 52-week high.
- That makes 10 straight losses.
- SEC filings that day: 8-K.
Oct 5, 2026 — KYNB slides 3.5% to $6.09, a 52-week low on 4.7x normal volume
- Closed at $6.09, -3.49% vs the prior close of $6.31. Day range $5.62–$6.45, opened at $6.36.
- Volume was 88.30K shares, 4.7x its 50-day average of 18.88K — unusually heavy trading.
- Price is -16.9% vs its 50-day average ($7.33) and -18.2% vs its 200-day average ($7.45).
- 52-week range $5.62–$12.13; today's close sits at 7% of that range, 49.8% below the 52-week high.
- That makes 9 straight losses.
Oct 2, 2026 — KYNB dips 2.9% to $6.31, a 52-week low, 8 down days in a row
- Closed at $6.31, -2.92% vs the prior close of $6.50. Day range $6.30–$6.64, opened at $6.60.
- Volume was 26.10K shares, 1.4x its 50-day average of 18.44K.
- Price is -14.1% vs its 50-day average ($7.35) and -15.5% vs its 200-day average ($7.46).
- 52-week range $6.30–$12.13; today's close sits at 0% of that range, 48.0% below the 52-week high.
- That makes 8 straight losses.
KYNB latest news & SEC filings
Every SEC filing by or about KYNB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 6, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: -$1.47M (prior year $1.35M) (loss widened vs Jun 30, 2025)
- Net income: $11.97M (prior year -$7.60M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $2.96 (prior year -$1.88) (swung to profit vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade KYNB
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 16, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.67% (largest 9.5%).
- Liquidity: about 24.39K shares (≈$118.29K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.85 vs a range of $4.85–$11.65 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:25 on Jun 17, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 0 sales; latest: Thane Wettig bought 2,800 shares on May 14, 2026.
- Latest filings: 8-K Oct 6, 2026; 8-K Oct 1, 2026; 8-K Aug 31, 2026.
- Share count: 4.05M shares outstanding (Jul 31, 2026), +0.1% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
KYNB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 5.39 | 5.50 | 4.85 | 4.85 | 28.50K |
| Oct 15, 2026 | 5.50 | 5.73 | 5.34 | 5.36 | 31.60K |
| Oct 14, 2026 | 5.89 | 5.90 | 5.46 | 5.57 | 36.70K |
| Oct 13, 2026 | 6.21 | 6.21 | 5.87 | 5.87 | 15.90K |
| Oct 12, 2026 | 6.15 | 6.34 | 6.01 | 6.12 | 23.60K |
| Oct 9, 2026 | 6.08 | 6.26 | 6.08 | 6.11 | 6.60K |
| Oct 8, 2026 | 6.15 | 6.16 | 5.90 | 5.96 | 15.00K |
| Oct 7, 2026 | 5.85 | 6.35 | 5.85 | 6.13 | 16.80K |
| Oct 6, 2026 | 6.14 | 6.14 | 5.87 | 5.96 | 13.70K |
| Oct 5, 2026 | 6.36 | 6.45 | 5.62 | 6.09 | 88.30K |
| Oct 2, 2026 | 6.60 | 6.64 | 6.30 | 6.31 | 26.10K |
| Oct 1, 2026 | 6.64 | 6.84 | 6.49 | 6.50 | 24.00K |
| Sep 30, 2026 | 6.67 | 6.93 | 6.60 | 6.65 | 25.50K |
| Sep 29, 2026 | 6.80 | 6.95 | 6.64 | 6.79 | 18.00K |
| Sep 28, 2026 | 6.96 | 7.12 | 6.83 | 6.90 | 12.20K |
| Sep 25, 2026 | 7.01 | 7.01 | 6.90 | 6.94 | 19.70K |
| Sep 24, 2026 | 7.18 | 7.18 | 6.98 | 7.00 | 15.50K |
| Sep 23, 2026 | 7.09 | 7.30 | 7.03 | 7.25 | 29.10K |
| Sep 22, 2026 | 7.15 | 7.28 | 6.99 | 7.28 | 22.50K |
| Sep 21, 2026 | 7.10 | 7.26 | 7.03 | 7.20 | 18.50K |
About Kyntra Bio
Kyntra Bio (KYNB) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN FRANCISCO, CA. Fiscal year ends December 31. SEC CIK 921299.
KYNB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jeffrey L Edwards | Director | Jun 17, 2026 |
| Maykin Ho | Director | Jun 17, 2026 |
| Michael Kauffman | Director | Jun 17, 2026 |
| James A Schoeneck | Director | Jun 17, 2026 |
| Thane Wettig | CEO | Sep 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David Delucia | Chief Financial Officer | Sep 9, 2026 |
| Thane Wettig | CEO | Sep 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 14, 2026 | Thane Wettig | Buy | 2,800 | $7.09 |
| May 14, 2026 | Thane Wettig | Buy | 2,800 | $7.09 |
| May 14, 2026 | Thane Wettig | Buy | 2,800 | $7.09 |
| May 14, 2026 | Thane Wettig | Buy | 2,800 | $7.09 |
| May 14, 2026 | Thane Wettig | Buy | 2,800 | $7.09 |
| May 14, 2026 | Thane Wettig | Buy | 2,800 | $7.09 |
| May 14, 2026 | Thane Wettig | Buy | 2,800 | $7.09 |
| May 14, 2026 | Thane Wettig | Buy | 2,800 | $7.09 |
| Nov 17, 2025 | Thane Wettig | Buy | 2,700 | $9.10 |
| Nov 17, 2025 | Thane Wettig | Buy | 2,700 | $9.10 |
| Nov 17, 2025 | Thane Wettig | Buy | 2,700 | $9.10 |
| Nov 17, 2025 | Thane Wettig | Buy | 2,700 | $9.10 |
| Nov 13, 2025 | Thane Wettig | Buy | 1,000 | $9.18 |
| Nov 13, 2025 | Thane Wettig | Buy | 1,000 | $9.18 |
| Nov 13, 2025 | Thane Wettig | Buy | 1,000 | $9.18 |
KYNB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $6.44M | $183.45M | 45.37 | $-4.77M |
| Dec 31, 2024 | $29.62M | $-47.58M | -11.89 | $-138.00M |
| Dec 31, 2023 | $46.80M | $-284.23M | -2.92 | $-315.02M |
| Dec 31, 2022 | $140.73M | $-293.65M | -3.14 | $-145.93M |
| Dec 31, 2021 | $235.31M | $-290.02M | -3.14 | $-82.23M |
Latest balance sheet: total assets $101.08M, total liabilities $109.22M, cash $50.64M (as of Jun 30, 2026).
KYNB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $7.04 |
| May 11, 2026 | 8-K Item 2.02 (results) | $6.80 |
| Mar 16, 2026 | 8-K Item 2.02 (results) | $7.00 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $11.00 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $8.37 |
| May 12, 2025 | 8-K Item 2.02 (results) | $7.62 |
| Mar 17, 2025 | 8-K Item 2.02 (results) | $11.12 |
| Feb 20, 2025 | 8-K Item 2.02 (results) | $19.30 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $9.68 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Feb 26, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on KYNB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.